IL160938A - Coniosulphides and their derivatives, processes for preparing them and their use as pharmaceuticals - Google Patents
Coniosulphides and their derivatives, processes for preparing them and their use as pharmaceuticalsInfo
- Publication number
- IL160938A IL160938A IL160938A IL16093804A IL160938A IL 160938 A IL160938 A IL 160938A IL 160938 A IL160938 A IL 160938A IL 16093804 A IL16093804 A IL 16093804A IL 160938 A IL160938 A IL 160938A
- Authority
- IL
- Israel
- Prior art keywords
- coniosulphides
- pharmaceuticals
- derivatives
- preparing
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P11/00—Preparation of sulfur-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10146737A DE10146737A1 (en) | 2001-09-22 | 2001-09-22 | Coniosulfides and their derivatives, process for their preparation and use as medicines |
PCT/EP2002/009977 WO2003029495A2 (en) | 2001-09-22 | 2002-09-06 | Coniosulphides and their derivatives, method for their production and use as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
IL160938A true IL160938A (en) | 2010-11-30 |
Family
ID=7699903
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16093802A IL160938A0 (en) | 2001-09-22 | 2002-09-06 | Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals |
IL160938A IL160938A (en) | 2001-09-22 | 2004-03-18 | Coniosulphides and their derivatives, processes for preparing them and their use as pharmaceuticals |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16093802A IL160938A0 (en) | 2001-09-22 | 2002-09-06 | Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP1474440B1 (en) |
JP (2) | JP4287744B2 (en) |
AR (1) | AR036554A1 (en) |
AT (2) | ATE430131T1 (en) |
AU (1) | AU2002339519B2 (en) |
CA (1) | CA2461033C (en) |
DE (3) | DE10146737A1 (en) |
ES (2) | ES2314107T3 (en) |
IL (2) | IL160938A0 (en) |
MX (1) | MXPA04001951A (en) |
PE (1) | PE20030466A1 (en) |
WO (1) | WO2003029495A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3330252B1 (en) * | 2008-11-11 | 2020-02-12 | Signum Biosciences, Inc. | Isoprenyl compounds and methods thereof |
WO2019198825A1 (en) * | 2018-04-13 | 2019-10-17 | 国立大学法人京都大学 | Prophylactic, therapeutic, or diagnostic drug for alzheimer's disease using microorganism-derived compound |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9210393D0 (en) * | 1992-05-15 | 1992-07-01 | Merck Sharp & Dohme | Therapeutic agents |
FR2740454B1 (en) * | 1995-10-26 | 1997-11-21 | Rhone Poulenc Rorer Sa | PEPTIDES CAPABLE OF INHIBITING APP ENDOCYTOSIS AND CORRESPONDING NUCLEOTIDE SEQUENCES |
WO1998021327A1 (en) | 1996-11-08 | 1998-05-22 | Rhone-Poulenc Rorer S.A. | Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences |
NZ520697A (en) * | 2000-02-10 | 2005-11-25 | Aventis Pharma Sa | Partners of PTB1 domain of FE65, preparation and uses |
DE10060810A1 (en) | 2000-12-07 | 2002-06-20 | Aventis Pharma Gmbh | Coniosetin and derivatives thereof, processes for making and using the same |
-
2001
- 2001-09-22 DE DE10146737A patent/DE10146737A1/en not_active Withdrawn
-
2002
- 2002-09-03 PE PE2002000837A patent/PE20030466A1/en not_active Application Discontinuation
- 2002-09-06 IL IL16093802A patent/IL160938A0/en unknown
- 2002-09-06 JP JP2003532708A patent/JP4287744B2/en not_active Expired - Fee Related
- 2002-09-06 CA CA2461033A patent/CA2461033C/en not_active Expired - Fee Related
- 2002-09-06 MX MXPA04001951A patent/MXPA04001951A/en active IP Right Grant
- 2002-09-06 WO PCT/EP2002/009977 patent/WO2003029495A2/en active IP Right Grant
- 2002-09-06 EP EP02777014A patent/EP1474440B1/en not_active Expired - Lifetime
- 2002-09-06 ES ES02777014T patent/ES2314107T3/en not_active Expired - Lifetime
- 2002-09-06 AU AU2002339519A patent/AU2002339519B2/en not_active Ceased
- 2002-09-06 DE DE50212774T patent/DE50212774D1/en not_active Expired - Lifetime
- 2002-09-06 AT AT08000437T patent/ATE430131T1/en not_active IP Right Cessation
- 2002-09-06 EP EP08000437A patent/EP1903033B1/en not_active Expired - Lifetime
- 2002-09-06 AT AT02777014T patent/ATE407942T1/en not_active IP Right Cessation
- 2002-09-06 ES ES08000437T patent/ES2326563T3/en not_active Expired - Lifetime
- 2002-09-06 DE DE50213512T patent/DE50213512D1/en not_active Expired - Lifetime
- 2002-09-19 AR ARP020103525A patent/AR036554A1/en not_active Application Discontinuation
-
2004
- 2004-03-18 IL IL160938A patent/IL160938A/en not_active IP Right Cessation
-
2009
- 2009-02-04 JP JP2009023173A patent/JP2009149662A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE50212774D1 (en) | 2008-10-23 |
MXPA04001951A (en) | 2004-06-07 |
EP1903033A1 (en) | 2008-03-26 |
ES2326563T3 (en) | 2009-10-14 |
EP1474440B1 (en) | 2008-09-10 |
WO2003029495A3 (en) | 2004-02-26 |
DE50213512D1 (en) | 2009-06-10 |
JP4287744B2 (en) | 2009-07-01 |
JP2005504131A (en) | 2005-02-10 |
CA2461033C (en) | 2011-12-06 |
ATE407942T1 (en) | 2008-09-15 |
ATE430131T1 (en) | 2009-05-15 |
IL160938A0 (en) | 2004-08-31 |
EP1474440A2 (en) | 2004-11-10 |
WO2003029495A2 (en) | 2003-04-10 |
PE20030466A1 (en) | 2003-07-08 |
DE10146737A1 (en) | 2003-04-10 |
AU2002339519B2 (en) | 2007-02-08 |
ES2314107T3 (en) | 2009-03-16 |
AR036554A1 (en) | 2004-09-15 |
JP2009149662A (en) | 2009-07-09 |
CA2461033A1 (en) | 2003-04-10 |
EP1903033B1 (en) | 2009-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI347201B (en) | Pharmaceutical products,uses thereof and methods for preparing the same | |
HK1089768A1 (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
IL160440A0 (en) | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments | |
AU2002365516A1 (en) | Benzamide derivatives, processes for their preparation, and their pharmaceutical use | |
HUP0402264A3 (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof | |
HUP0303729A3 (en) | Novel heteroaryl derivatives and the use thereof as pharmaceuticals and process for their preparation | |
HUP0401648A3 (en) | 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same | |
TWI319764B (en) | Mercaptoacetylamide derivatives, a process for their preparation and their use | |
HK1068336A1 (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents | |
MXPA03006538A (en) | Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use. | |
MXPA03008630A (en) | Arylisoxazoline derivatives, method for production and use thereof as pesticides. | |
IL162316A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t | |
PL350190A1 (en) | Epothilon derivatives, method for the production and the use thereof as pharmaceuticals | |
MXPA03006478A (en) | Chromane derivatives, process for their preparation and their use as antitumor agents. | |
IL164248A0 (en) | Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use | |
MXPA03006249A (en) | 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof. | |
IL164815A0 (en) | Halosulfonylbenzoyl halides, processes for their preparation and their use for preparing substitutedphenylsulfonylureas | |
IL160606A0 (en) | C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals | |
IL160938A0 (en) | Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals | |
IL159561A0 (en) | Eurotinones and derivatives thereof, processes for preparing them, and their use | |
IL160608A0 (en) | C2-substituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals | |
IL157793A0 (en) | Caloporoside derivatives, methods for the production thereof and their use | |
AU2003264894A8 (en) | Novel method for preparing alpha-glycosylceramides, novel alpha-glycosylceramide derivatives and their uses | |
AU2002333449A1 (en) | C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments | |
EP1515960A4 (en) | 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |